IRIS
CENCI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 260
AS - Asia 215
EU - Europa 188
SA - Sud America 3
AF - Africa 1
Totale 667
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 259
CN - Cina 120
SG - Singapore 86
SE - Svezia 66
RU - Federazione Russa 48
IT - Italia 36
FI - Finlandia 16
DE - Germania 13
AE - Emirati Arabi Uniti 5
IE - Irlanda 2
IN - India 2
NL - Olanda 2
PE - Perù 2
UA - Ucraina 2
BR - Brasile 1
CA - Canada 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LT - Lituania 1
MA - Marocco 1
Totale 667
Salva come PNG Salva come JPEG
Città #
Singapore 60
Shanghai 42
Ashburn 31
Boardman 26
Lawrence 26
Princeton 26
New York 18
Moscow 14
Helsinki 13
Milan 13
Dallas 7
Guangzhou 6
Los Angeles 6
Seattle 6
Wuxi 6
Dubai 5
Washington 5
Shenzhen 4
Beijing 3
Lappeenranta 3
Quanzhou 3
Verona 3
Ancona 2
Dublin 2
Jiaxing 2
Landshut 2
Lima 2
Mozzagrogna 2
Mykolayiv 2
Presezzo 2
Pune 2
Santa Clara 2
Bishkek 1
Bologna 1
Chapel Hill 1
Dalian 1
Foshan 1
Handan 1
Hangzhou 1
Harbin 1
Hefei 1
Hong Kong 1
Issogne 1
Jinhua 1
Naaldwijk 1
Nanyang 1
Newark 1
Reykjavik 1
Rome 1
Saint Martinville 1
San Diego 1
San Francisco 1
Sezze 1
Sioux Falls 1
Sopron 1
Toronto 1
Wuhu 1
Xi'an 1
Yancheng 1
Yiwu 1
Totale 374
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 26
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 26
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 24
Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation 24
Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by ¹H HR-MAS NMR Metabolomics. 23
Autophagy in Plasma Cell Ontogeny and Malignancy 21
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 20
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 19
Iron increases the susceptibility of multiple myeloma cells to bortezomib 19
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors 19
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 19
The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis 19
A New Fluorogenic Peptide Determines Proteasome Activity in Single Cells 18
FAM46C-dependent tuning of endoplasmic reticulum capacity in Multiple Myeloma 17
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation 17
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 17
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE 16
Autophagy and longevity: Evolutionary hints from hyper-longevous mammals 16
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells 16
Autophagy, a new determinant of plasma cell differentiation and antibody responses 16
MHC Class II Transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity 16
Autophagy in Plasma Cells 15
Managing and exploiting stress in the antibody factory 15
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 15
Editorial: Advances in Plasma Cells in Health and Disease 14
CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells 14
Plasma cells require autophagy for sustainable immunoglobulin production 14
Ex vivo gene expression of osteoblasts in maxillary sinus grafting 14
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma 12
Metabolomics of B to Plasma Cell Differentiation 12
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel 11
B lymphocytes inhibit human osteoclastogenesis by secretion of TGF beta 11
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator 11
Autophagy in plasma cell pathophysiology 11
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition 11
The problem of arteriovenous malformations of the spinal cord in the elderly: Case report of an octogenarian 10
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 10
Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo 10
PROGRESSIVELY IMPAIRED PROTEASOMAL CAPACITY DURING TERMINAL PLASMA CELL DIFFERENTIATION 10
Proteostenosis and Plasma Cell Pathophysiology 10
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 9
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling 9
A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver 8
Proteotoxic stress and cell lifespan control 8
Toll-like receptor 9 stimulation can induce I kappa B zeta expression and IgM secretion in chronic lymphocytic leukemia cells 8
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator 8
Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease 7
Autophagy in the regulation of protein secretion in immune cells 7
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis 6
PROTEOSTASIS AS A SIGNALING DEVICE AND THERAPEUTIC TARGET 6
Therapeutic Efficacy of Hematopoietic Stem Cell Gene Therapy for Hurler Type 1 Mucopolysaccharidosis 6
Hip fracture in nursing homes: An Italian study on prevalence latency, risk factors, and impact on mobility 5
Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency 5
Short-term reproducibility of proximal femur bone mineral density in the elderly 5
M-CSF neutralization and Egr-1 deficiency prevent ovariectomy-induced bone loss 4
The role of autophagy in plasma cell ontogenesis 4
Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines 4
Recent advances and future directions in targeting the secretory apparatus in multiple myeloma 4
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma 3
The Proteasome in Terminal Plasma Cell Differentiation 3
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 3
HMGB1, an evolving pleiotropic protein critical for cellular and tissue homeostasis: role in aging and age-related diseases 2
IRON CONTRIBUTES TO BORTEZOMIB SENSITIVITY IN MULTIPLE MYELOMA CELLS 2
T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and -independent mechanisms 2
null 1
null 1
Totale 768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 1 0 0 0 0 0 0
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202218 0 0 2 6 1 3 3 0 3 0 0 0
2022/2023153 58 30 6 0 1 15 3 5 6 18 10 1
2023/2024344 38 31 62 30 19 37 9 37 0 8 13 60
2024/2025234 86 19 47 50 32 0 0 0 0 0 0 0
Totale 768